Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This is a revolution in science
Skipping doses, expecting instant results or being inconsistent with supplementation can slow progress, especially for skin-brightening goals
Weight loss peptides (GLP-1 RAs) Originally developed as diabetes treatments, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) exhibit mechanisms of action on metabolism and the pancreas that promote weight loss by:26 Slowing digestion: A longer time to gastric emptying correlates not only with a decreased appetite but also with a milder glucose spike.27 28 A decreased appetite means less desire to consume excess calories, and a less severe spike indicates tighter regulation over a significant weight-gain factor.29 Increasing feelings of fullness: When you do get hungry, a GLP-1 RA can help you reach satiety sooner than you normally would
The satiety effect is additive with GLP-1 agonism because the pathways don't overlap which is why CagriSema outperforms semaglutide monotherapy and tirzepatide on some endpoints
This makes it easier to model dose-response relationships, timing controls, and environmental condition testing
